Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cencora, Inc. | Director | Common Stock | 2.41K | $571K | $237.47 | Mar 12, 2024 | Direct |
Adagio Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 44.2K | Jun 22, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
COR | Cencora, Inc. | Mar 12, 2024 | 1 | $0 | 4 | Mar 13, 2024 | Director |
ABC | AMERISOURCEBERGEN CORP | Mar 9, 2023 | 1 | $0 | 4 | Mar 13, 2023 | Director |
ABC | AMERISOURCEBERGEN CORP | Feb 1, 2023 | 1 | $0 | 4 | Feb 3, 2023 | Director |
ABC | AMERISOURCEBERGEN CORP | Jan 1, 2023 | 0 | $0 | 3 | Jan 5, 2023 | Director |
IVVD | Adagio Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
IVVD | Adagio Therapeutics, Inc. | Nov 19, 2021 | 1 | $0 | 4 | Nov 23, 2021 | Director |
IVVD | Adagio Therapeutics, Inc. | Nov 19, 2021 | 0 | $0 | 3 | Nov 22, 2021 | Director |